Events Past Events Immunovant Discusses Initial Results From ASCEND GO 1, An Open-Label Phase 2a trial of IMVT-1401 In Thyroid Eye Disease, and Provides Corporate Update Mar 30, 2020 at 8:30 AM EDT Click here for webcast Immunovant at SVB Leerink 9th Annual Global Healthcare Conference Feb 25, 2020 at 3:00 PM EST Click here for webcast Immunovant and Health Sciences Acquisitions Corporation Discuss Plans To Merge Oct 11, 2019 at 8:30 AM EDT Webcast
Immunovant Discusses Initial Results From ASCEND GO 1, An Open-Label Phase 2a trial of IMVT-1401 In Thyroid Eye Disease, and Provides Corporate Update Mar 30, 2020 at 8:30 AM EDT Click here for webcast
Immunovant at SVB Leerink 9th Annual Global Healthcare Conference Feb 25, 2020 at 3:00 PM EST Click here for webcast
Immunovant and Health Sciences Acquisitions Corporation Discuss Plans To Merge Oct 11, 2019 at 8:30 AM EDT Webcast
